NanoViricides
NNVC
33 hedge funds and large institutions have $1.87M invested in NanoViricides in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 8 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
8% more capital invested
Capital invested by funds: $1.74M → $1.87M (+$132K)
1.19% less ownership
Funds ownership: 9.5% → 8.31% (-1.2%)
11% less funds holding
Funds holding: 37 → 33 (-4)
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$153K |
| 2 |
VF
Virtu Financial
New York
|
+$29.3K |
| 3 |
FIA
Foundations Investment Advisors
Phoenix,
Arizona
|
+$13.7K |
| 4 |
Renaissance Technologies
New York
|
+$7.65K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.65K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$273K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$41.1K |
| 3 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
-$30.5K |
| 4 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
-$25.9K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$24.8K |
NNVC Hedge Fund Activity: Q2 2025 in Review
33 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q2 2025, worth a combined $1.87M — up 7.6% from $1.74M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of NNVC and 5 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 8 added.
The largest buyer was UBS Group, adding an estimated $153K. The largest seller was Compagnie Lombard Odier SCmA, exiting entirely with an estimated $273K sold.
- 33 institutional investors held NanoViricides (NNVC) as of Q2 2025, down from 37 in Q1 2025.
- Funds reported $1.87M of NanoViricides stock for Q2 2025, up 7.6% quarter-over-quarter.
- 5 funds opened new NanoViricides positions in Q2 2025 and 8 closed out, a net change of -3 holders.
- The largest NanoViricides buyer in Q2 2025 was UBS Group, an estimated $153K added.
- The largest NanoViricides seller in Q2 2025 was Compagnie Lombard Odier SCmA, an estimated $273K sold.
Based on aggregated 13F filings for Q2 2025.